Jong-Seo Lee
Vermogen: 19 M $ op 31-07-2026
Vermogen: 19 M $ op 31-07-2026
Jong-Seo Lee is the founder.
Dr. Lee is the Chief Executive Officer & Director at AbClon, Inc., founded in 2010.
Education history includes a graduate degree from Yonsei University, a doctorate from Kyoto University, and an undergraduate degree from Sogang University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABCLON, INC. 7,03% | 27-04-2026 | 1.401.675 ( 7,03% ) | 19 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ABCLON INC. | Oprichter | 25-06-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyoto University
Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sogang University
Sogang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbClon, Inc.
AbClon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of antibody drugs | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau